126 related articles for article (PubMed ID: 38344808)
21. KIF2C: a novel link between Wnt/β-catenin and mTORC1 signaling in the pathogenesis of hepatocellular carcinoma.
Wei S; Dai M; Zhang C; Teng K; Wang F; Li H; Sun W; Feng Z; Kang T; Guan X; Xu R; Cai M; Xie D
Protein Cell; 2021 Oct; 12(10):788-809. PubMed ID: 32748349
[TBL] [Abstract][Full Text] [Related]
22. Kinesin family member 2C promotes hepatocellular carcinoma growth and metastasis via activating MEK/ERK pathway.
Ding Q; Jiang C; Zhou Y; Duan J; Lai J; Jiang M; Lin D
Biosci Biotechnol Biochem; 2021 Oct; 85(11):2241-2249. PubMed ID: 34494081
[TBL] [Abstract][Full Text] [Related]
23. Large-Scale Transcriptome Data Analysis Identifies KIF2C as a Potential Therapeutic Target Associated With Immune Infiltration in Prostate Cancer.
Zhang P; Gao H; Ye C; Yan R; Yu L; Xia C; Yang D
Front Immunol; 2022; 13():905259. PubMed ID: 35720323
[TBL] [Abstract][Full Text] [Related]
24. KIF2C Is a Novel Prognostic Biomarker and Correlated with Immune Infiltration in Endometrial Cancer.
An L; Zhang J; Feng D; Zhao Y; Ouyang W; Shi R; Zhou X; Yu Z; Wei S; Min J; Wang H
Stem Cells Int; 2021; 2021():1434856. PubMed ID: 34650608
[TBL] [Abstract][Full Text] [Related]
25. KIF2C exerts an oncogenic role in nonsmall cell lung cancer and is negatively regulated by miR-325-3p.
Gan H; Lin L; Hu N; Yang Y; Gao Y; Pei Y; Chen K; Sun B
Cell Biochem Funct; 2019 Aug; 37(6):424-431. PubMed ID: 31328811
[TBL] [Abstract][Full Text] [Related]
26. KIF2C is a critical regulator for malignant progression of head and neck squamous cell carcinoma.
Zhu H; Bao Y; Dou X; Zuo X; Ye J; Ma H; Bu Y; Wang Y; Zhu J
Am J Cancer Res; 2024; 14(5):2538-2554. PubMed ID: 38859848
[TBL] [Abstract][Full Text] [Related]
27. KIF2C Facilitates Tumor Growth and Metastasis in Pancreatic Ductal Adenocarcinoma.
Huang X; Zhao F; Wu Q; Wang Z; Ren H; Zhang Q; Wang Z; Xu J
Cancers (Basel); 2023 Feb; 15(5):. PubMed ID: 36900292
[TBL] [Abstract][Full Text] [Related]
28. MCAK Inhibitors Induce Aneuploidy in Triple-Negative Breast Cancer Models.
Smith JC; Husted S; Pilrose J; Ems-McClung SC; Stout JR; Carpenter RL; Walczak CE
Cancers (Basel); 2023 Jun; 15(13):. PubMed ID: 37444419
[TBL] [Abstract][Full Text] [Related]
29. Activation of the TGF-β1/Smad signaling by KIF2C contributes to the malignant phenotype of thyroid carcinoma cells.
Lin Q; Qi Q; Hou S; Chen Z; Jiang N; Zhang L; Lin C
Tissue Cell; 2021 Dec; 73():101655. PubMed ID: 34624565
[TBL] [Abstract][Full Text] [Related]
30. Knockdown of kinesin family member 2C restricts cell proliferation and induces cell cycle arrest in gastric cancer.
Li S; Ma Y; Wu C; Hou X
Histol Histopathol; 2023 Aug; 38(8):907-916. PubMed ID: 36448588
[TBL] [Abstract][Full Text] [Related]
31. KIF2C accelerates the development of non-small cell lung cancer and is suppressed by miR-186-3p via the AKT-GSK3β-β-catenin pathway.
Guo J; Zhang W; Sun L; Yu H; Wang Y; Feng L; Yang H
Sci Rep; 2023 May; 13(1):7288. PubMed ID: 37142638
[TBL] [Abstract][Full Text] [Related]
32. Molecular insight into the regulation and function of MCAK.
Ritter A; Kreis NN; Louwen F; Wordeman L; Yuan J
Crit Rev Biochem Mol Biol; 2015; 51(4):228-45. PubMed ID: 27146484
[TBL] [Abstract][Full Text] [Related]
33. Ablation of KIF2C in Purkinje cells impairs metabotropic glutamate receptor trafficking and motor coordination in male mice.
Zheng R; Xu FX; Zhou L; Xu J; Shen Y; Hao K; Wang XT; Deng J
J Physiol; 2023 Sep; 601(17):3905-3920. PubMed ID: 37431690
[TBL] [Abstract][Full Text] [Related]
34. MCAK facilitates chromosome movement by promoting kinetochore microtubule turnover.
Wordeman L; Wagenbach M; von Dassow G
J Cell Biol; 2007 Dec; 179(5):869-79. PubMed ID: 18039936
[TBL] [Abstract][Full Text] [Related]
35. Kinesin family members KIF2C/4A/10/11/14/18B/20A/23 predict poor prognosis and promote cell proliferation in hepatocellular carcinoma.
Li X; Huang W; Huang W; Wei T; Zhu W; Chen G; Zhang J
Am J Transl Res; 2020; 12(5):1614-1639. PubMed ID: 32509165
[TBL] [Abstract][Full Text] [Related]
36. Mitotic centromere-associated kinesin (MCAK): a potential cancer drug target.
Sanhaji M; Friel CT; Wordeman L; Louwen F; Yuan J
Oncotarget; 2011 Dec; 2(12):935-47. PubMed ID: 22249213
[TBL] [Abstract][Full Text] [Related]
37. Silencing of KIF2C enhances the sensitivity of hepatocellular carcinoma cells to cisplatin through regulating the PI3K/AKT/MAPK signaling pathway.
Wei S; Lu C; Mo S; Huang H; Chen M; Li S; Kong L; Zhang H; Hoa PTT; Han C; Luo X
Anticancer Drugs; 2024 Mar; 35(3):237-250. PubMed ID: 38170762
[TBL] [Abstract][Full Text] [Related]
38. Kinesin superfamily protein expression and its association with progression and prognosis in hepatocellular carcinoma.
Chen J; Li S; Zhou S; Cao S; Lou Y; Shen H; Yin J; Li G
J Cancer Res Ther; 2017; 13(4):651-659. PubMed ID: 28901309
[TBL] [Abstract][Full Text] [Related]
39. Insight into microtubule disassembly by kinesin-13s from the structure of Kif2C bound to tubulin.
Wang W; Cantos-Fernandes S; Lv Y; Kuerban H; Ahmad S; Wang C; Gigant B
Nat Commun; 2017 Jul; 8(1):70. PubMed ID: 28694425
[TBL] [Abstract][Full Text] [Related]
40. Distinct Diagnostic and Prognostic Values of Kinesin Family Member Genes Expression in Patients with Breast Cancer.
Song X; Zhang T; Wang X; Liao X; Han C; Yang C; Su K; Cao W; Gong Y; Chen Z; Han Q; Li J
Med Sci Monit; 2018 Dec; 24():9442-9464. PubMed ID: 30593585
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
